|
"hsu c"的相关文件
显示项目 831-855 / 881 (共36页)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2006 |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.; CHONG-JEN YU; Chen K.-C.; Yang C.-H.; Shih J.-Y. |
| 淡江大學 |
2005-09 |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su, W.P.; Wen, C.C.; Hsiung, C.A.; Su, I.J.; Cheng, A.L.; Chang, M.C.; Tsao, C.J.; Kao, W.Y.; Uen, W.C.; Hsu, C.; Hsu, C.H.; Lu, Y.S.; Tien, H.F; Chao, T.Y.; Chen L.T.; Jacqueline Whang-Peng; Chen, P.J. |
| 國家衛生研究院 |
2005-08 |
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis
|
Shen, YC;Chang, CJ;Hsu, C;Cheng, CC;Chiu, CF;Cheng, AL |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立臺灣大學 |
2005-08 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. |
| 國立東華大學 |
2005-07 |
Exploiting Hardware-accelerated Occlusion Queries for Visibility Culling
|
Yang,M.T.; Hsu,C.; Chiang,C.; Tai,W. |
| 國家衛生研究院 |
2005-05 |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Hsieh, FJ; Cheng, AL |
| 國立臺灣大學 |
2005-05 |
Strategic planning of developing automatic optical inspection (AOI) technologies in Taiwan
|
Fan, K. C.; Hsu, C. |
| 國家衛生研究院 |
2005 |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL |
| 臺北醫學大學 |
2005 |
Project for Stroke Prevention Center. Prevalence and Arsenic Exposure in Taiwan.
|
邱弘毅; Chiou HY;Chiu WT;Chen YH;Hsieh YC;Hsu C; |
| 高雄醫學大學 |
2005 |
Alteration of protein kinase C isoforms expressions in various regions of rat ventricles during sepsis
|
梁馨仁;許勤;許勝光;呂勝義;楊瑞成;楊秀蘭 ; Liang HJ;Hsu C;Hsu HK;Lue SI;Yang RC;Yang SL |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
謝雅晶;饒曉菁;許勝光;黃麗如;許勤 ; Hsieh YC;Chen YH;Jao HC;Hsu HK;Huang LJ;Hsu C |
| 高雄醫學大學 |
2005 |
Role of cAMP-response element-binding protein phosphorylation in hepatic apoptosis under protein kinase C alpha suppression during sepsis.
|
陳彥旭; Hsieh, YC;Chen, YH;Jao, HC;Hsu, HK;Huang, LJ;Hsu, C |
| 國立臺灣大學 |
2005 |
Fractionation and identification of pparα activators in the oxidized frying oil
|
Hsu, C; Chao, PM; Kuo, YH; Huang, C-j* |
| 國立臺灣大學 |
2005 |
A Question of Trust-An Economics Analysis of Quality Standards in Certification Services Market
|
Backhouse, J; Hsu, C; Tseng, J; Baptista, J |
| 臺大學術典藏 |
2005 |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Cheng A.-L.; Hsieh F.-J.; Wu C.-Y.; Chen L.-T.; CHIUNG-NIEN CHEN; Hsu C.; Hsu C.;Chiung-Nien Chen;Chen L.-T.;Wu C.-Y.;Hsieh F.-J.;Cheng A.-L. |
| 國立臺灣大學 |
2004-12 |
Use of power Doppler sonography and circulating angiogenic factors to assess the anti-angiogenic effect of thalidomide in hepatocellular carcinoma.
|
Hsu, C; Chen, CN; Chen, LT; Wu, CY; Hsieh, FJ; Cheng, AL |
| 國家衛生研究院 |
2004-10-18 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, YC; Hsu, C; Chen, JY; Cheng, AL |
| 國立臺灣大學 |
2004-10-05 |
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
|
Shen, Y.C.; Hsu, C.; Chen, J.Y.; Cheng, A.L. |
| 國家衛生研究院 |
2004-10 |
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of hepatocellular carcinoma
|
Cha'ang, H;Lien, P;Tsen, S;Hsu, C;Shih, T |
| 國家衛生研究院 |
2004-07 |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
Hsu, C;Cheng, JCH;Cheng, AL |
| 國家衛生研究院 |
2004-07 |
Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)
|
Hsu, C;Chen, LT;Lai, MY;Yeh, KH;Lee, PH;Cheng, AL |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 國立臺灣大學 |
2004-05 |
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
|
Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
显示项目 831-855 / 881 (共36页)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每页显示[10|25|50]项目
|
